{"database": "lobbying", "table": "lobbying_activities", "rows": [[2869376, "42d44aea-d72b-412d-9b37-d26fea02c24b", "Q3", "MS. TAMI WAHL", 401104405, "TRADITIONAL MEDICINALS", 2022, "third_quarter", "FOO", "To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).", "HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)", null, null, 0, 0, "2022-10-17T18:37:19-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2869376"], "units": {}, "query_ms": 39.10082299262285, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}